Drug intelligence / Profile preview

2,6-diaminoquinazolin-4-ol

Development stage
Unknown
Modality
Small Molecules
01

Overview

2,6-diaminoquinazolin-4-ol is a synthetic small molecule belonging to the quinazoline family of heterocyclic aromatic compounds. Its structure features a quinazoline core substituted with amino groups at positions 2 and 6 and a hydroxyl group at position 4. This compound has been primarily studied as an experimental chemical entity rather than as an approved pharmaceutical drug. Quinazoline derivatives are known for their broad pharmacological activities—including antimalarial and kinase inhibitory properties—but there is no evidence that this specific compound has reached clinical development or approval for any indication[1][8]. It is mainly used in research settings to explore the biological activity of quinazolines or as an intermediate in medicinal chemistry[1][8].

Other names
2,6-diaminoquinazolin-4-ol2,6-Diamino-4(1H)-quinazolinone2,6-Diamino-4-hydroxyquinazolineDQU
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on 2,6-diaminoquinazolin-4-ol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 2,6-diaminoquinazolin-4-ol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call